Urinary prostaglandin E2 metabolite and gastric cancer risk in the Shanghai women's health study.

MLA

Dong, Linda M., et al. “Urinary Prostaglandin E2 Metabolite and Gastric Cancer Risk in the Shanghai Women’s Health Study.” Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, vol. 18, no. 11, Nov. 2009, pp. 3075–78. EBSCOhost, https://doi.org/10.1158/1055-9965.EPI-09-0680.

APA

Dong, L. M., Shu, X.-O., Gao, Y.-T., Milne, G., Ji, B.-T., Yang, G., Li, H.-L., Rothman, N., Zheng, W., Chow, W.-H., & Abnet, C. C. (2009). Urinary prostaglandin E2 metabolite and gastric cancer risk in the Shanghai women’s health study. Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 18(11), 3075–3078. https://doi.org/10.1158/1055-9965.EPI-09-0680

Chicago

Dong, Linda M, Xiao-Ou Shu, Yu-Tang Gao, Ginger Milne, Bu-Tian Ji, Gong Yang, Hong-Lan Li, et al. 2009. “Urinary Prostaglandin E2 Metabolite and Gastric Cancer Risk in the Shanghai Women’s Health Study.” Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 18 (11): 3075–78. doi:10.1158/1055-9965.EPI-09-0680.